Key result
In a neonatal lamb model of pathologic biventricular hypertrophy created by aorta-pulmonary shunts, myocardial transactivators are upregulated while repressors are downregulated.
The shunted neonatal lamb serves as a valid model of pathologic biventricular hypertrophy, demonstrating that myocardial transactivators are upregulated and repressors are downregulated during disease progression.
Answers are grounded in this paper and cite their sources.
Supports transcriptional target exploration in neonatal hypertrophy; leaves open translation to human congenital heart disease.
OBJECTIVES: In the current study we describe and characterize a novel ovine model of biventricular hypertrophy and heart failure and evaluate the role of selected cardiac transcription factors in the regulation of cardiac gene expression during pathologic hypertrophy in vivo. The cardiac troponin T promoter is used as a model gene. METHODS AND RESULTS: Transient transfections of ovine cardiomyocytes in culture show that Sp1, transcriptional enhancer factor-1, and myocyte enhancer factor-2 activate cardiac troponin T promoter constructs. Cotransfection of Sp3 inhibits cardiac troponin T promoter activity and represses Sp1-mediated activation of the cardiac troponin T promoter. By chromatin immunoprecipitation, transcriptional enhancer factor-1, myocyte enhancer factor-2, NKX2.5, GATA-4, and Sp factors bind the cardiac troponin T promoter in vivo. To assess the role of cardiac transcription during pathologic hypertrophy, in vivo, we created surgical aorta-pulmonary shunts in utero in fetal lambs. Two weeks after spontaneous delivery, shunted lambs showed failure to thrive, significant biventricular hypertrophy, and heart failure. Shunted hearts had significant increases in myosin and cardiac troponin T protein expression. There was a shift in expression to the high-molecular-weight fetal isoforms. Transcriptional enhancer factor-1, myocyte enhancer factor-2, GATA-4, NKX2.5, and Sp1 transcription factor levels were increased in all heart chambers of shunted animals. Sp3 expression was decreased in shunted ventricles. Immunoprecipitated Sp3 was associated with significant increases in histone acetyl transferase activity and decreases in histone-deacetylase activity. CONCLUSION: The shunted neonatal lamb is a valid, novel model of pathologic biventricular hypertrophy. During pathologic hypertrophy myocardial transactivators are upregulated while repressors are downregulated.
No takes yet. Share an insight, caveat, or question.
Azakie et al. (2006) studied biventricular hypertrophy and heart failure. surgical aorta-pulmonary shunts was evaluated on cardiac transcription factor levels and cardiac troponin T protein expression. In a neonatal lamb model of pathologic biventricular hypertrophy created by aorta-pulmonary shunts, myocardial transactivators are upregulated while repressors are downregulated.
Synapse has enriched 10 related papers. Consider them for comparative context: